Warning: Patients Receiving Extraneal (icodextrin) for Peritoneal Dialysis Therapy May Have Falsely Elevated Blood...
Patients receiving EXTRANEAL (icodextrin) for peritoneal dialysis therapy may have falsely elevated blood glucose results when using certain blood glucose monitoring systems.
Disetronic Medical Systems Inc. announced a voluntary nationwide recall of the Disetronic D-TRONplus Power Packs, that power the D-TRONplus Insulin Pump.
The ADA sent a letter to express reservations with proposed Medicaid reforms put forward by President George W. Bush.
Diabetes mellitus was linked to a 65 percent increased risk of developing Alzheimer's disease (AD), appearing to affect some aspects of cognitive function differently than others in a new study.
A recent study shows that interventional radiologists can use an innovative technique to relieve the pain that plagues millions of amputees, many of which...
A study by researchers at the Joslin Diabetes Center has shown that adherence to prescribed dietary recommendations is associated with better glucose control in children with type 1 diabetes.
Researchers have halted the course of early stage Type 1 diabetes for a year by treating patients for just two weeks with a new immune-suppressive drug, which only had minor side effects.
A new study shows that a regimen of three medications helped people with Type 1 diabetes achieve better blood glucose control and shed pounds. A...
A diet designed to imitate the effects of fasting appears to reverse diabetes for type 1 and type 2 diabetes by reprogramming cells, a...
A recent study provides some insight as to why diabetic patients are more likely to die from alcohol-related factors, accidents or suicide.
A team of researchers has found that a common family of viruses may play an important role in triggering the development of diabetes, particularly in children.
There is currently no evidence available of a superiority of rapid-acting insulin analogues over human insulin in the treatment of adult patients with diabetes mellitus type 1.
Interference With Blood Glucose Measurement Following Use of Parenteral Maltose/Galactose/Oral Xylose-Containing Products
Potential for life-threatening falsely elevated glucose readings in patients who have received parenteral products containing maltose or galactose, or oral xylose, and are subsequently tested using glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) based glucose monitoring systems.
A newly discovered gene plays a dramatic role in diabetes among rats, and is also present in nearly identical form in humans.
To minimize that pain and inconvenience, researchers at MIT's Spectroscopy Laboratory have developed a noninvasive way to measure blood glucose levels using light.
Researchers have discovered a new potential therapy that can protect human pancreatic cells, which may lead to a possible cure for type 1 diabetes. New...